|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1 Suppl
|
|
pubmed:dateCreated |
2002-1-31
|
|
pubmed:abstractText |
Gastric cancers with serosal invasion often spread to the peritoneal surface. Beneficial effects of hypotonic intraperitoneal cisplatin against peritoneal dissemination was noted in experimental models. Prophylactic hypotonic intraperitoneal cisplatin during operation should therefore be examined in human gastric cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0039-6060
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
131
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
S98-104
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11821794-Adult,
pubmed-meshheading:11821794-Aged,
pubmed-meshheading:11821794-Antineoplastic Agents,
pubmed-meshheading:11821794-Cisplatin,
pubmed-meshheading:11821794-Female,
pubmed-meshheading:11821794-Gastrectomy,
pubmed-meshheading:11821794-Humans,
pubmed-meshheading:11821794-Hypotonic Solutions,
pubmed-meshheading:11821794-Infusions, Parenteral,
pubmed-meshheading:11821794-Intraoperative Care,
pubmed-meshheading:11821794-Male,
pubmed-meshheading:11821794-Middle Aged,
pubmed-meshheading:11821794-Osmolar Concentration,
pubmed-meshheading:11821794-Peritoneal Cavity,
pubmed-meshheading:11821794-Stomach Neoplasms
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
The administration of hypotonic intraperitoneal cisplatin during operation as a treatment for the peritoneal dissemination of gastric cancer.
|
|
pubmed:affiliation |
Department of Surgery I, Faculty of Medicine, Tottori University, Yonago, Japan.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase I
|
